Special Edition: 'Molly' as Medicine? Psychedelics, PTSD & One Veteran's Journey
The NewsWorthy
Erica Mandy
3.9 • 1.3K Ratings
🗓️ 23 May 2026
⏱️ 27 minutes
🧾️ Download transcript
Summary
When no other treatment made a meaningful difference for his severe PTSD, Marine Corps veteran Scott Rush turned to a promising, yet unconventional, option: MDMA-assisted therapy.
We first spoke with him five years ago after he took part in a study using the psychedelic drug, so on this Memorial Day weekend, we're checking back in to hear how he's doing now, and why he says that experience changed the course of his life.
Then, we talked with Dr. Jennifer Mitchell, the lead scientist from that same study, about where the science stands today, what concerns remain, and what to make of new efforts to speed up the research.
Learn more about our guest(s): https://www.theNewsWorthy.com/shownotes
Join us again for our 10-minute daily news roundups every Mon-Fri!
Become an INSIDER and get ad-free episodes here: https://www.theNewsWorthy.com/insider
Get The NewsWorthy MERCH here: https://www.theNewsWorthy.com/merch
Sponsors:
Head to Greenchef.com/50NEWSWORTHY and use code 50NEWSWORTHY to get 50% off your first month, then 20% off for two months.
Get Hiya's best-selling children's vitamins! Receive 50% off your first order. To claim this deal you must go to hiyahealth.com/NEWSWORTHY.
To advertise on our podcast, please email: ad-sales@libsyn.com
Transcript
Click on a timestamp to play from that location
| 0:00.0 | My nightmares went away. I felt less quick to anger and, like, violence. I've noticed that |
| 0:05.5 | MDMA was sort of the start of the dominoes that fell into place. I started to make big |
| 0:11.2 | changes in my life. Today is Saturday, May 23rd. And today we're talking about psychedelic drugs |
| 0:19.3 | and their potential use as medicine. |
| 0:21.6 | The last time we did an episode about this was almost exactly five years ago, when we introduced |
| 0:26.3 | you to the Marine veteran Scott Rush. He took part in a study that used MDMA, better known by |
| 0:31.3 | the street name's Ecstasy and Molly, to help treat post-traumatic stress disorder. At the time, |
| 0:36.5 | he told us it was the first thing that made a significant difference for him. |
| 0:40.0 | And now, years later, he's sharing how that experience helped change the course of his life. |
| 0:44.9 | Of course, PTSD is a big issue here in the United States, especially among our armed forces. |
| 0:49.5 | So on this Memorial Day weekend, as we remember and honor fallen service members, |
| 0:53.9 | we wanted to check back in |
| 0:55.0 | with Scott as we continue to learn more about this potential yet unconventional treatment for the |
| 0:59.5 | troops who did make it home and are still suffering. Then later in the show, we're also getting an |
| 1:04.6 | update from the lead scientist from the same study, Dr. Jennifer Mitchell. She helps us understand |
| 1:09.4 | where the science stands now. But first, here's my |
| 1:12.1 | follow-up conversation with Marine Corps veteran Scott Rush, who says he struggled with PTSD for more |
| 1:16.8 | than a decade after coming home from Iraq until three MDMA-assisted treatments did for him |
| 1:22.0 | what other treatments couldn't. Welcome to the Newsworthy Special Edition Saturday, when we sit down with a different |
| 1:29.5 | expert or celebrity every Saturday to talk about something in the news. |
| 1:33.0 | Don't forget to tune in every Monday through Friday for our regular episodes where we |
| 1:36.8 | provide all the day's news in less than 15 minutes. |
... |
Transcript will be available on the free plan in 14 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Erica Mandy, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Erica Mandy and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

